Clinical Role - Hospital

Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.

FDA Green Lights Generic Drug for Certain Patients with Prostate Cancer
Glenmark Pharmaceuticals has received FDA approval for abiraterone acetate tablets USP, 250 mg, a generic of Janssen's Zytiga tablets, 250 mg.1
Practice Pearl 1: Addressing Reluctance to Use SQ Dosing
Potential clinical and financial causes for hesitation in the transition to subcutaneous dosing are addressed.
New Treatment Available for “Off” Episodes in Patients with Parkinson Disease
Kyowa Kirin’s istradefylline (Nourianz) is now available in the United States as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) that are experiencing “off” episodes.
Trending News Today: Study Finds Medicare for All Costs $32 Trillion Over 10 Years
Top news of the day from across the health care landscape.
 
Practice Pearl 1: Educating Staff on SQ Dosing
Experts provide perspective on how they prepare their staff for the transition to subcutaneous dosing.
Showing Staff Appreciation on Pharmacy Technician Day
Today is National Pharmacy Technician Day, and pharmacists are sharing how valuable technicians are to them. 
Report: Prescription Drug Prices Climb Nearly 26% in 3 Years
In the wake of California’s drug transparency law, an analysis by state health officials on pricing trends found that drug companies raised the whole acquisition cost dramatically for many drugs.
Rite Aid Foundation Grants $2.3 Million to Local Children's Hospitals
The Rite Aid Foundation is awarding $2.3 million to Children’s Miracle Network Hospitals through its KidCents Grant Program. 
FDA Approves Rivaroxaban for Blood Clots in Acutely Ill Medical Patients
To date, the FDA has granted rivaroxaban 8 indications, 6 of which are specifically for the treatment, prevention, and reduction in the risk of recurrence of venous thromboemolism across a wide range of patient populations.
Researcher Awarded $7.5 Million in Funding for COPD Research
A researcher at the Washington University School of Medicine in St.Louis has received close to $7.5 million in total funding for research towards development of stem cell-based treatments for chronic pulmonary disease (COPD), asthma, and other disorders.
FDA Grants Awarded to Rare Disease Research Tops SPT Week in Review
Top news of the week from Specialty Pharmacy Times. 
12 Difficult-to-Pronounce Drug Names, Part 3
This article is the third in a series on difficult to pronounce drug names.
+ Load More